Similar articles

• Augmentation of paroxetine with clocapramine in panic disorder.

  Saito M, Miyaoka H. Saito M, et al. Psychiatry Clin Neurosci. 2007 Aug;61(4):449. doi: 10.1111/j.1440-1819.2007.01690.x. Psychiatry Clin Neurosci. 2007. PMID: 17610675 No abstract available.
• Treatment of panic disorder: focus on paroxetine.

  Pollack MH, Doyle AC. Pollack MH, et al. Psychopharmacol Bull. 2003 Spring;37 Suppl 1:53-63. Psychopharmacol Bull. 2003. PMID: 14566201 Review.
• [Clinical effect and tolerance of paxil (paroxetine) in management of panic disorders].

  Mosolov SN, Smulevich AB, Nuller IuL, Grigor'evskikh VS, Kostiukova EG, Kuzavkova MV, Koliutskaia EV, Andriushchenko AV, Zelenina EV, Kosinskiĭ VP, Kozlovskiĭ VL, Bykov SI, Pererva IG. Mosolov SN, et al. Ter Arkh. 2000;72(10):16-23. Ter Arkh. 2000. PMID: 11220870 Clinical Trial. Russian.
• Efficacy studies of paroxetine in panic disorder.

  Lydiard RB, Steiner M, Burnham D, Gergel I. Lydiard RB, et al. Psychopharmacol Bull. 1998;34(2):175-82. Psychopharmacol Bull. 1998. PMID: 9640997 Review.
• Personality disorders and response to medication treatment in panic disorder: a 1-year naturalistic study.

  Marchesi C, De Panfilis C, Cantoni A, Fontò S, Giannelli MR, Maggini C. Marchesi C, et al. Prog Neuropsychopharmacol Biol Psychiatry. 2006 Sep 30;30(7):1240-5. doi: 10.1016/j.pnpbp.2006.03.010. Epub 2006 May 6. Prog Neuropsychopharmacol Biol Psychiatry. 2006. PMID: 16678956